[Development of tyrosine kinase inhibitors for hematologic neoplasms. FLT3 and JAK2 as therapeutic targets].
about
[Development of tyrosine kinase inhibitors for hematologic neoplasms. FLT3 and JAK2 as therapeutic targets].
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
[Development of tyrosine kinas ...... JAK2 as therapeutic targets].
@en
[Development of tyrosine kinas ...... JAK2 as therapeutic targets].
@nl
type
label
[Development of tyrosine kinas ...... JAK2 as therapeutic targets].
@en
[Development of tyrosine kinas ...... JAK2 as therapeutic targets].
@nl
prefLabel
[Development of tyrosine kinas ...... JAK2 as therapeutic targets].
@en
[Development of tyrosine kinas ...... JAK2 as therapeutic targets].
@nl
P2093
P356
P1476
[Development of tyrosine kinas ...... d JAK2 as therapeutic targets]
@en
P2093
Christoph Huber
Florian Heidel
Thomas Fischer
P304
P356
10.1002/PAUZ.200800280
P407
P577
2008-01-01T00:00:00Z